52 in 52: The Rivers Trial


    52 in 52: The Rivers Trial

    Title: “The 52 in 52 Review: Early goal-directed therapy in the treatment of severe sepsis and septic shock”

    Article Citation: Rivers E, Nguyen B, Havstad S, Ressler J, et al; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 Nov 8;345(19):1368-77. PMID: 11794169.

    What we already know about the topic: In patients with sepsis or septic shock, inflammatory changes causes circulatory abnormalities such as intravascular volume depletion, peripheral vasodilatation, myocardial depression, and increased metabolism which can then lead to an imbalance between systemic oxygen delivery and oxygen demand, resulting in global tissue hypoxia. Goal-directed therapy,  involving targeted adjustments of preload, afterload, and contractility to balance oxygen delivery with oxygen demand has been used for severe sepsis and septic shock in the ICU setting.

    Why this study is important: In this study, the authors evaluate the efficacy of early goal-directed therapy before admission to the intensive care unit, as defined by intensive monitoring of specific circulatory parameters with the aggressive management of 5 key parameters to specified targets to optimize oxygen delivery to tissues. This was one of the first studies to look at the effects of starting aggressive protocolized care early on in the ED treatment of septic patients.

    Brief overview of the study: The Rivers trial randomized 263 patients with severe sepsis or septic shock at a single urban Detroit ED to a protocol of early goal-directed therapy (EGDT) vs. standard therapy. In the EGDT arm, patients received an arterial line and a central line with continuous central venous oxygen saturation (ScvO2) monitoring. The EGDT group consisted of several sequential goals in the ER prior to ICU admission: CVP 8-12mmHg, achieved with fluid boluses, MAP >65mmHg, achieved with vasopressors if necessary, ScvO2 >70%, achieved with packed RBC transfusions and dobutamine if necessary, and UOP >0.5mL/kg/hr. The study found thatthe EGDT arm had a 16% absolute risk reduction in mortality.

    Limitations: There are several limitations in the Rivers trial, which subsequent studies such as ProCESS tried to address. First, ED staff taking care of patients could not be blinded due to the nature of the intervention. Secondly, the study has been criticized for a “Rivers effect” — that is, having a dedicated critical care trained doctor taking care of patients in the intervention arm. Based on the trial, it’s also difficult to determine what decreased mortality in patients and whether it was the entire EGDT protocol or a component. Finally, patients who received EGDT all received additional fluid (4.9 L vs. 3.5 L (P<0.001)) and additional blood product (0-6 hours: 64.1% vs. 18.5% (P<0.001)) compared to those in the standard treatment arm, which in the critically ill could be harmful due to fluid overload.

    Take home points: While the Rivers trial was groundbreaking in that it demonstrated adopting early goal directed care prior to the ICU decreased mortality in septic patients, the study had several limitations. Subsequent multi-center trials such as ProCESS, ProMISe and ARISE demonstrated that in patients who are recognized early on as having sepsis and treated with intravenous fluids and antibiotics, there was no significant benefit in EGDT.

    • Welcome! This is the website for the Mount Sinai Emergency Ultrasound Division. It serves as an information resource for residents, fellows, medical students and others seeking information about point-of-care ultrasound. There is a lot ofRead more

    • Central Line Wizardry

      I was scrolling through twitter this morning when I came across a quick video from @CriticalCareNow for an awesome central line trick. And then I went to his feed and found some more. They areRead more

    • Let’s wait for the “official urinalysis”….?

      Chances are you order a urine dip or urinalysis on a good number of your patients each shift. But how good are these tests at helping us diagnose a urinary tract infection? The short answer:Read more

    • National Physician Suicide Awareness Day

      This past Tuesday (September 17th) was the first annual National Physician Suicide Awareness Day. CORD, ACEP, SAEM and a number of other EM organizations paired with organization from other specialties to raise awareness of theRead more

    • M is for morphine

      Remember MONA (morphine, oxygen, nitro, aspirin) from med school? Well, she may be just “A” now…. Over the years, all of these treatments (except for good old aspirin) have become somewhat controversial in the treatmentRead more

    • Meningitis Prophylaxis

      Have you ever taken care of really critical, undifferentiated patient, only later to find out that they were diagnosed with a serious, contagious illness? We are exposed to innumerable pathogens each day in the ED,Read more

    • The Betel Nut: an oral carcinogen

      Ever walk up to a stable, comfortable appearing patient at Elmhurst and their mouth/teeth are completely RED? Or maybe like a dark brownish/black color? Like this?? It really scared me the first I saw itRead more

    • The Fascia Iliaca compartment block: as magical as it sounds!

      In case you haven’t gotten to this month’s EM:RAP, there’s a really great segment on an important ED procedure that we definitely don’t do enough of in the ED: the nerve block. The section discussesRead more

    • Hurry Up & RUSH!

      You’re working in RESUS, and you get a notification for hypotension. He’s a 65 year old male noted to be hypotensive to 70/40 by EMS. On arrival, he’s altered and unable to provide any history,Read more